World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
18376
World Ranking
2409
National Ranking
23

Per thor Straten publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Per thor Straten sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 280 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Per thor Straten D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Per thor Straten sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Per thor Straten is affiliated with the University of Copenhagen in Denmark. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with 53 and 31 publications respectively. Their work is more specialized within subfields including Immunology, Oncology, Molecular Biology, Rehabilitation, and Genetics.

The main topics explored in their research encompass Exercise and Physiological Responses, Immune Cell Function and Interaction, CAR-T cell therapy research, Immunotherapy and Immune Responses, Phagocytosis and Immune Regulation, Virus-based gene therapy research, and Cancer Immunotherapy and Biomarkers.

Among recent publications, the following key papers are notable:

  • TAM Receptor Inhibition-Implications for Cancer and the Immune System (2021, Cancers)
  • Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial (2020, Journal for ImmunoTherapy of Cancer)
  • Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens (2021, Frontiers in Immunology)
  • Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe? (2021, Cancers)
  • Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo (2020, International Journal of Molecular Sciences)

Frequent co-authors in their research collaborations include:

  • Anne Rahbech
  • Gitte Holmen Olofsson
  • Marlies J. W. Peeters
  • Pia Aehnlich
  • Özcan Met

Their publications are often found in venues centered on immunology and oncology, including:

  • Frontiers in Immunology
  • Regular and Young Investigator Award Abstracts
  • Cancers
  • Advanced Healthcare Materials
  • Cytotherapy

Best Publications

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution

    Line Pedersen;Manja Idorn;Gitte H. Olofsson;Britt Lauenborg

  • Cytotoxic T Cells

    Mads Hald Andersen;David Schrama;Per thor Straten;Jürgen C. Becker

  • Disruption of the MMAC1/PTEN Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma

    P. Guldberg;P. Thor Straten;A. Birck;V. Ahrenkiel

  • Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very Elderly

    Sine Reker Hadrup;Jan Strindhall;Tania Køllgaard;Tina Seremet

  • Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers

    Rikke Sick Andersen;Pia Kvistborg;Thomas Mørch Frøsig;Thomas Mørch Frøsig;Natasja Wulff Pedersen

  • Somatic Fas Mutations in Non-Hodgkin's Lymphoma: Association With Extranodal Disease and Autoimmunity

    Kirsten Grønbæk;Per thor Straten;Elisabeth Ralfkiaer;Vibeke Ahrenkiel

  • Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment

    Sine Reker Hadrup;Marco Donia;Per Thor Straten

  • Collagen density regulates the activity of tumor-infiltrating T cells

    Dorota E. Kuczek;Anne Mette Hvid Larsen;Anne Mette Hvid Larsen;Marie-Louise Thorseth;Marco Carretta

  • Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

    Sine Reker Hadrup;Sine Reker Hadrup;Arnold H Bakker;Arnold H Bakker;Chengyi J Shu;Rikke S Andersen

  • Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

    Mads Hald Andersen;Lars Østergaard Pedersen;Jürgen C. Becker;Per thor Straten

  • Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3-Dependent Expression of MHC Class I-Related Chain A and B

    Søren Skov;Marianne Terndrup Pedersen;Lars Andresen;Per Thor Straten

  • Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes

    Amalie Kai Bentzen;Andrea Marion Marquard;Rikke Lyngaa;Sunil Kumar Saini

  • Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients

    Mads Hald Andersen;Lars Ø. Pedersen;Barbara Capeller;Eva-Bettina Bröcker

  • Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

    Rikke Andersen;Marco Donia;Eva Ellebaek;Troels Holz Borch

  • Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

    Lotte Engell-Noerregaard;Troels Holz Hansen;Mads Hald Andersen;Per thor Straten

  • Immune-suppressive properties of the tumor microenvironment

    Jürgen C. Becker;Mads Hald Andersen;David Schrama;Per thor Straten

  • Expression of stress-induced MHC class I related chain molecules on human melanoma.

    Claudia S. Vetter;Veronika Groh;Per Thor Straten;Thomas Spies

  • The universal character of the tumor-associated antigen survivin.

    Mads Hald Andersen;Inge Marie Svane;Jürgen C. Becker;Per thor Straten

  • Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.

    Manja Idorn;Tania Køllgaard;Per Kongsted;Lisa Sengeløv

Frequent Co-Authors

Mads Hald Andersen
Mads Hald Andersen Copenhagen University Hospital
Inge Marie Svane
Inge Marie Svane Copenhagen University Hospital
Jürgen C. Becker
Jürgen C. Becker University of Duisburg-Essen
Marco Donia
Marco Donia Copenhagen University Hospital
Sine Reker Hadrup
Sine Reker Hadrup Technical University of Denmark
Per Guldberg
Per Guldberg University of Southern Denmark
Eva-B. Bröcker
Eva-B. Bröcker University of Würzburg
Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Christian H. Ottensmeier
Christian H. Ottensmeier University of Southampton
Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various specialized fields in healthcare and research. For those interested in hands-on patient care alongside immunological expertise, exploring an accelerated FNP program can be a strategic pathway. These programs quickly equip students with the skills to become Family Nurse Practitioners, blending fast-track education with clinical practice.

For individuals without a nursing background, enrolling in 12-month accelerated nursing programs online for non nurses provides a rapid entry into the nursing profession. These programs are designed to accommodate career changers, offering comprehensive training within a year while maintaining flexibility through online formats.

Among these accelerated options, some 12-month accelerated nursing programs stand out for their accessibility and streamlined admission processes. They cater to students eager to complete their Bachelor of Science in Nursing efficiently without compromising educational quality.

Additionally, for those aiming to start their healthcare journey sooner, LPN programs easy to get into offer a practical pathway. Licensed Practical Nurse programs provide foundational clinical skills and serve as stepping stones for further nursing or immunology-related education.

Best Scientists Citing Per thor Straten

Trending Scientists

Recently Published Articles